FDA Investigator Travis M Beard

Travis M Beard has conducted inspections on 134 sites in 4 countries as of 03 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
134
Last Inspection Date:
03 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100000590
Countries of Inspections:
United States of America, Spain, New Zealand, Israel
FDA Investigators that have inspected at least one site in common with Travis M Beard:
Abby Lmozeke Baker, Adam C Hipko, Akbar J Zaidi, Alanna L Mussawwir Bias, Alcee M Tavarez, Amanda J White, Andrace L Deyampert, Andrea A Branche, Angela Mock, Anh M Lac, Ann Marie Karnick, Annette Melendez, Anthony J Grace, Anya Dlockett Evans, Astrid M Rylander, Audrey J Yarbrough, Betsy C Galliher, Bing Lin, Brandon K Barbee, Brandon L Mariner, Brandon O Neloms, Brian J Ryan, Camille D Brown, Cathleen A Castellaw, Charles D Brown, Christina D Mello, Christopher D Rush, Christopher J Smith, Connie L Hannon Rabel, Corrine M Carter, Cynthia A Harris, MD, RN, Daniel B Bordt, Daniel J Lahar, Daniell Gill, Jr, Danny D Horner, David M Beltran, Denise Connelly, Deniza Karacic, Ed Gonzalez Vazquez, Elisa M Fleming, Elizabeth D Connell, Elmina E Akwo, Elmina E Mboh, Enspect User, Ernest Serna, III, Gatica, Gene R Gunn, Grant L Davis, Gregory A Holt, H Ljamilla Selby, Habacuc V Barrera, Hala L Selby, Iris C Macinnes, J Elkins, Jacey Roy, Jacob W Reynolds, Jamie M Bumpas, Janet B Abt, Jennifer Hua, Jennifer O Dowdy, Jeremy L Stukes, Jeremy W Rotton, Joanne M Schlossin, Jodi M Gatica, Joel D Martinez, Kamara Tx, Karen C Daugherty, Karen M Kondas, Karlton T Watson, Kelly J Pegg, Ladislav Kermet, Lan T Tran, Latorie S Jones, Lauren R Brady, Lauren R Howell, Leighton Kn Gai, Leon L Crawley, Lisa A Doyle, Lisa M Puttonen, Lloyd D Payne, Lorie S Hannappel, Lourdes Andujar, Lourdes R Genera, Luis E Gonzalez, Maotang Zhou, PhD, Marc R Dickens, Margaret M Annes, Marilyn S Babu, Marlene L Davis, Michele M Falchek, Monique S Frazier, Ninfa N Innocent, Patrick D Stone, MS, Patty P Kaewussdangkul, Pauline N Logan, Payne, Philip M Steele, PhD, Phillip D Waldron, Ralph H Vocque, Raman K Kaushal, Rebecca Rodriguez, Rene R Ramirez, Rhonda L Dash, Ronda Rloyd Jones, Roy Baby, Ruth E Medcalf, Saijal P Naik, Samantha J Pinizzotto, D V M, Sara A Valenzuela, Scott T Ballard, Shawn E Larson, Sherrie L Krolczyk, Stacey F Rivette, Staci G Mcallister, Stephen D Brown, Stephen L Beekman, Tamera H Hunt, Terrance L Thomas, Terri E Gibson, Theresa Kirkham (NMI), Thomas J Arista, Toby Vern H Hill, Torrance J Slayton, Tracy J Washington, Travis S Brown, Trina K Vick, William A Warnick, Yaw O Osei, Young M Yoon, Zerita White

Travis M Beard's Documents

Publish Date Document Type Title
January, 2022 EIR Ann R. Woodbridge, M.D. - EIR, 2022-01-24
February, 2016 EIR John D. Gabriel, MD - EIR, 2016-02-18
October, 2016 FDA 483 Rajinder S. Shiwach, M.D. - Form 483, 2016-10-21
November, 2021 FDA 483 Claudia R. Padilla, M.D. - Form 483, 2021-11-12
June, 2016 FDA 483 William R Lumry, M.D. - Form 483, 2016-06-09
June, 2016 EIR William R Lumry, M.D. - EIR, 2016-06-09
November, 2016 FDA 483 Response Adolfo Kaplan - Form 483R, 2016-11-14
June, 2019 EIR Covance Clinical Research Unit, Inc. - EIR, 2019-06-07
February, 2016 FDA 483 Response John D. Gabriel, MD - Form 483R, 2016-02-18
June, 2022 EIR Travere Therapeutics, Inc. - EIR, 2022-06-23
July, 2021 EIR REATA PHARMACEUTICALS - EIR, 2021-07-13
January, 2022 FDA 483 Ann R. Woodbridge, M.D. - Form 483, 2022-01-24
July, 2021 FDA 483 Robert G. Szewc MD - Form 483, 2021-07-01
November, 2016 FDA 483 Adolfo Kaplan - Form 483, 2016-11-10
February, 2016 FDA 483 John D. Gabriel, MD - Form 483, 2016-02-18
January, 2024 FDA 483 Philip NMI Raskin - Form 483, 2024-01-11
May, 2022 FDA 483 Shahrukh A. Kureishy, MD - Form 483, 2022-05-09
July, 2018 FDA 483 Henry Okonkwo, P.A. - Form 483, 2018-07-01
August, 2023 FDA 483 Aslan T Turer, M.D. - Form 483, 2023-08-16
June, 2019 FDA 483 Covance Clinical Research Unit, Inc. - Form 483, 2019-06-07
October, 2017 FDA 483 Latha Prasannan, MD - Form 483, 2017-09-29
November, 2019 FDA 483 Muhammad S. Beg MD - Form 483, 2019-11-22
April, 2024 FDA 483 Rajinder S. Shiwach, M.D. - Form 483, 2024-04-25

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more